- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01967420
Cognitive Remediation for First Episode of Psychosis Patients
Using Computerised Training to Improve Cognition and Functioning in the First Episode of Psychosis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A first episode of psychosis is defined as the first experience of positive symptoms, such as hallucinations and delusions, and the behaviour that accompanies it. This is associated with problems in many areas of cognition; the ability to acquire knowledge and understanding. These cognitive symptoms have been found to have a large impact on daily functioning (e.g. accessing education or employment and maintaining relationships) and cannot effectively be treated with medication. Cognitive remediation (CR) is a therapy that aims to improve cognition and, through generalisation of this, improve daily functioning and quality of life. Although it is an area of deficit, social cognition, the ability to perceive and understand emotional states, is often not targeted in cognitive remediation. However, interventions which have focused on providing social cognition training (SCT) alongside CR have shown large improvements in daily functioning.
This study aims to look at the effectiveness of a combination of CR and SCT to improve cognition and functioning when compared to CR alone. The target population will be those who are experiencing their first episode of psychosis. Participants will be recruited from an Early Intervention in Psychosis service which is an NHS service set up to provide rapid treatment for those experiencing psychosis.
Participants will take part in a ten week CR or CR+SCT intervention which will consist of spending 90 minutes a week in a small group setting working through a series of computer games which aim to improve cognition. Interviews and questionnaires regarding daily functioning, cognition, quality of life and symptoms will be used before and after the intervention. Participants will be asked to attend follow-up interviews 6 months after the intervention has ended to complete the measures again to see if any beneficial effects have lasted.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
West Yorkshire
-
Bradford, West Yorkshire, United Kingdom, BD1 2EP
- Bradford Early Intervention in Psychosis Service
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Non-affective psychosis
- Premorbid IQ of over 70
- A service user of the early intervention service
- Aged 18 or over (up to the age of 35 which is the limit for the early intervention service)
- Psychiatrically stable enough to attend to completion (no hospitalisations or medication changes in last 4 weeks)
Exclusion Criteria:
- Active substance dependency
- History of severe head injury
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cognitive remediation plus social cognition training
A combined intervention of 60 minutes of computerised cognitive remediation and 30 minutes of computerised social cognition training.
|
CIRCuiTS is a computerised cognitive remediation program which consists of tasks to improve cognition, the use of strategy training and the teaching of generalisable community functioning skills.
Other Names:
The social cognition training is a computerised program which aims to improve emotion recognition through a variety of lessons and games.
Other Names:
|
|
Active Comparator: Cognitive remediation alone
An active control condition consisting of 60 minutes of computerised cognitive remediation and 30 minutes of free computer time.
|
CIRCuiTS is a computerised cognitive remediation program which consists of tasks to improve cognition, the use of strategy training and the teaching of generalisable community functioning skills.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Emotion Recognition Task
Time Frame: 10 weeks
|
The emotion recognition task of the computerised Cambridge neuropsychological test automated battery (CANTAB).
|
10 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
CANTAB schizophrenia battery
Time Frame: 10 weeks and 6 month follow-up
|
Additional computerised neuropsychological tests from the CANTAB schizophrenia battery will be used.
These are the rapid visual information processing task (RVP), the spatial working memory task (SWM), the paired associates learning task (PAL), one touch stockings of Cambridge task (OTS) and the intra-extra dimensional set shift task (IED).
|
10 weeks and 6 month follow-up
|
|
Specific levels of functioning scale (SLOF)
Time Frame: 10 weeks and 6 month follow-up
|
SLOF is an observer-rated set of 6 domains of functioning where ratings are made on 5-point Likert scales based on how often a particular behaviour occurs or how much help is required to perform certain tasks.
The 6 domains are: physical functioning, personal care skills, interpersonal relationships, social acceptability, activities and work skills, the final four of which will be used in this study.
This will be completed with the participant's primary care team and verified with the participant.
|
10 weeks and 6 month follow-up
|
|
Personal and Social Performance Scale (PSP)
Time Frame: 10 weeks and 6 month follow-up
|
An additional measure of functioning, the PSP will be added on to the end of the SLOF.
The PSP addresses 4 domains: socially useful activities, personal and social relationships, self-care, and disturbing and aggressive behaviours.
It is scored on a 1-100 scale.
This is a validated and reliable measure of functioning with high test-retest reliability.
It will be completed by a member of the participant's care team.
|
10 weeks and 6 month follow-up
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Emily Beetschen, University of Manchester
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 13/NW/0385
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psychosis
-
Columbia UniversityNational Institute of Mental Health (NIMH); University of California, Davis; University... and other collaboratorsRecruitingClinical High Risk | First Episode Psychosis | Early PsychosisUnited States
-
University of OxfordWellcome Trust; Jazz PharmaceuticalsNot yet recruitingClinical High Risk for Psychosis | Clinical High Risk for Psychosis (CHR) | Clinical High Risk for Developing PsychosisUnited Kingdom, Italy, Greece, Finland, Germany, Netherlands, Austria, Canada, Spain, Switzerland
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)Enrolling by invitationFirst Episode Psychosis (FEP) | Clinical High Risk for Psychosis (CHR)United States
-
University of New MexicoNational Institute of Mental Health (NIMH)CompletedPsychosis | Clinical High Risk for Psychosis | First Episode PsychosisUnited States
-
Elazığ Mental Health and Diseases HospitalRecruitingMethamphetamine Induced PsychosisTurkey (Türkiye)
-
Columbia UniversityNational Institute of Mental Health (NIMH)RecruitingClinical High Risk | First Episode Psychosis | Early PsychosisUnited States
-
Shanghai Jiao Tong University School of MedicineGuangzhou Psychiatric Hospital; Suzhou Psychiatric Hospital; Tianjin Anding Hospital and other collaboratorsRecruitingSchizophrenia; Psychosis | Clinical High Risk | First Episode PsychosisChina
-
University of OxfordHospital General Universitario Gregorio Marañon; Charite University, Berlin... and other collaboratorsNot yet recruitingPsychosis | Treatment Resistant PsychosisSpain, United Kingdom, Germany, Israel, Greece, Italy, Netherlands, Switzerland
-
Chulalongkorn UniversityNational Research Council of Thailand; Thanyarak InstituteCompletedMethamphetamine-induced PsychosisThailand
-
Université de SherbrookeBaszucki Brain Research FundNot yet recruitingMetabolic Disease | Psychosis; Episode | First Episose PsychosisCanada
Clinical Trials on Cognitive remediation
-
Queen's UniversityCompleted
-
Queen's UniversityPfizerCompleted
-
Yale UniversityCompletedCancer | Cancer of the ProstateUnited States
-
Fundació Sant Joan de DéuCompletedIndication for Modification of Patient Cognitive StatusSpain
-
VA Office of Research and DevelopmentCompleted
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH); Columbia UniversitySuspendedSchizophrenia | Schizoaffective DisorderUnited States
-
Queen's UniversityCompleted
-
University of GroningenLentis Psychiatric Institute; GGZ Friesland; Stichting CosisRecruitingSevere Mental IllnessNetherlands
-
Douglas Mental Health University InstituteMcGill University; Canadian Institutes of Health Research (CIHR)Recruiting
-
Gemma Garrido GarcíaCompleted